Previous 10 | Next 10 |
Rockwell Medical Provides Corporate and Clinical Update PR Newswire - Closes $7.5 Million Second Tranche Investment from DaVita - $30 Million in Total Capital Raised This Quarter - Receives Additional Feedback from FDA on its IND Application ...
Rockwell Medical (NASDAQ:RMTI) shed ~14% in the pre-market Wednesday after the healthcare supplier announced the resignation of its President and Chief Executive Officer Russell Ellison effective June 30. Mark Strobeck is expected to take over as the company’s new president a...
Rockwell Medical Closes $15 Million Financing from Leading Healthcare Investor PR Newswire WIXOM, Mich. , June 7, 2022 /PRNewswire/ -- Rockwell Medical , Inc. (Nasdaq: RMTI) has closed the previously announced $15 Million in financing, consisting ...
Rockwell Medical (NASDAQ:RMTI) was notified by the Nasdaq that it has regained compliance with the minimum bid price requirement for continued listing. Rockwell is now in compliance with all applicable listing standards and its common stock will continue to be listed on The Nasdaq. On Ju...
Rockwell Medical Regains Compliance with Nasdaq Listing Requirements PR Newswire WIXOM , Mich. , June 1, 2022 /PRNewswire/ -- Rockwell Medical , Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficienc...
Rockwell Medical (NASDAQ:RMTI) has announced a $15M at-market offering. The biopharmaceutical company entered into securities purchase agreements with Armistice Capital Master Fund to purchase $15M of common stock (or common stock equivalents in lieu thereof) and warrants; $12M of securities ...
Rockwell Medical Announces $15 Million At-Market Offering PR Newswire WIXOM, Mich. , May 31, 2022 /PRNewswire/ -- Rockwell Medical , Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia...
Rockwell Medical, Inc. to Present at H.C. Wainwright Annual Global Life Sciences Conference PR Newswire WIXOM, Mich. , May 23, 2022 /PRNewswire/ -- Rockwell Medical , Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical compa...
Rockwell Medical, Inc. (RMTI) Q1 2022 Earnings Conference Call May 16, 2022 16:15 ET Company Participants Jason Finkelstein - Investor Relations Russell Ellison - President and Chief Executive Officer Russell Skibsted - Executive Vice President, Chief Financial Officer and Chief Business Offi...
Rockwell Medical press release (NASDAQ:RMTI): Q1 GAAP EPS of -$0.84 beats by $0.15. Revenue of $16.12M (+4.2% Y/Y) misses by $1.53M. As of March 31, 2022, cash and cash equivalents and working capital totaled $9.9 million and $5.2 million, respectively. Amended and expanded supply agreement w...
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company's President and Chief Executive Officer, Dr. Mark Strobeck ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Tim Chole was promoted to Chief Commercial Officer, reporting to the ...